Tea drinking and haemostasis: A randomized, placebo-controlled, crossover study in free-living subjects

Pathophysiology of Haemostasis and Thrombosis

Volumn 26, Issue 1, 1996, Pages 58-64

  Vorster, Hester ^a   Jerling, Johann ^a   Oosthuizen, Welma ^a   Cummings, John ^b   Bingham, Sheila ^b   Magee, Liz ^b   Mulligan, Angela ^b   Runswick, Shirley ^b  

^a NORTH WEST UNIVERSITY   (South Africa)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Black tea; Fibrinogen; Plasminogen activator; Plasminogen activator inhibitor 1; Risk of coronary heart disease

Indexed keywords

4 AMINOBENZOIC ACID; PLACEBO; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; HUMAN; HUMAN EXPERIMENT; ISCHEMIC HEART DISEASE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SINGLE BLIND PROCEDURE; TEA;

ADULT; AGED; CORONARY DISEASE; CROSS-OVER STUDIES; DRINKING; FEMALE; FIBRINOGEN; FIBRINOLYSIS; HEMOSTASIS; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PLACEBOS; REFERENCE VALUES; RISK FACTORS; TEA;

EID: 0030047591     PISSN: 14248832     EISSN: 14248840     Source Type: Journal    
DOI: 10.1159/000217188     Document Type: Article

References (33)

1. Graham HN: Green tea consumption and polyphenol chemistry. Prev Med 1992;21:334-350.
2. Dietary flavonoids and risk of coronary heart disease. Nutr Rev 1994; 52:59-68.
3. Yang CS, Wang ZY: Teaandcancer. J Natl Cancer Inst 1993:85:1038-1049.
4. Hertog MGL, Fcskens EJM, Holl-man PCH, Katan MB. Kromhout D: Dietary antioxidant flavonoids and risk of coronary heart disease: The Zutphen Elderly Study. Lancet 1993;342:1007-1011.
5. Stcnsvold I, Tverdal A, Solvoll K, Foss OP: Tea consumption: Relationship to cholesterol, blood pressure. and coronary and total mortality. Prev Med 1992;21:546-553.
6. Green M, Harari G: Association of serum lipoproteins and health-related habits with coffee and tea consumption in free-living subjects examined in the Israeli CORDIS study. Prev Med 1992;21:532-545.
7. Green MS, Jucha E: Association of serum lipids with coffee, tea and egg consumption in free-living subjects. J Epidemiol Community Health 1986;40:324-329.
8. Brown CA, Bolton-Smith C, Woodward M, Tunstall-Pcdoc H: Coffee and tea consumption and the prevalence of coronary heart disease in men and women. Results from the Scottish Heart Health Study. J Epidemiol Community Health 1993; 47:171-175.
9. Klatsky AL, Petitti DB, Armstrong NIA, Friedman GD: Coffee, tea and cholesterol. Am J Cardiol 1985;55: 577-578.
10. Kark JD, Friedlander Y, Kaufmann NA, Stein Y: Coffee, tea and plasma cholesterol: The Jerusalem Lipid Research Clinic prevalence study. Brit Med J 1985;291:699-704.
11. Stone MC, Thorp JM: Plasma fibrinogen-A major coronary risk factor. J R Coll Gen Pract 1985;35: 565-569.
12. Meade TW, Mellows S, Brozovic M, Miller GJ. Chakrabarti R, North WRS, Haines AP, Stirling Y, Imc-son JD, Thompson SG: Haemostatic function and ischaemic heart disease: Principal results of the North-wick Park Heart Study. Lancet 1986;ii:533-537.
13. Kannel WB, Wolf PA, Castclli WP, D’Agostino RB: Fibrinogen and risk of cardiovascular disease: The Framingham Study. JAMA 1987; 258:1183-1186.
14. Balleisen L, Schulte H, Assmann G, Epping PH, Van de Loo J: Coagulation factors and the progress of coronary heart disease. Lancet 1987;ii: 461.
15. Meade TW, Ruddock V, Stirling Y, Chakrabarti R, Miller GJ: Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study. Lancet 1993,342: 1076-1079.
16. Tanaka K, Sueishi K: Biology of disease: The coagulation and fibrinolysis systems and atherosclerosis. Lab Invest 1993;69:5-18.
17. Lijnen HR, Collen D: Regulation and control of the fibrinolytic system; in: Festoff BW (ed): Serine Proteases and their Serpin Inhibitors in the Nervous System. New York, Plenum, 1990;pp 9-20.
18. Mehta J. Mehta P, Lawson D, Sal-deen T: Plasma tissue plasminogen activator inhibitor levels in coronary artery disease: Correlation with age and scrum triglyceride concentrations. J Am Coll Cardiol 1987;9: 26.
19. Aimer LO, Ohlin H: Elevated levels of the rapid inhibitor of plasminogen activator in acute myocardial infarction. Thromb Res 1987,47:335-339.
20. Hamsten A, Defaire U, Walldius G, Dahlen G, Szamosi A, Landou C, Blomback M, Wiman B: Plasminogen activator inhibitor in plasma: Risk factor for recurrent myocardial infarction. Lancet 1987;ii:3-9.
21. Ogston D, Lea AG, Langhorne P, Wilson SB: The influence of the polyphenols of cider on plasmin and plasminogen activators. Br J Haematol 1985;60:705-713.
22. Laughton MJ. Evans PJ. Moroney MA, Hoult JRS, Halliwell B: Inhibition of mammalian 5-lipoxygenase and cyclo-oxygenase by flavonoids and phenolic dietary additives: Relationship to antioxidant activity and iron-reducing ability. Biochem Pharmacol 1991;42:1673-1681.
23. Ali M, Afzal M: A potent inhibitor of thrombin stimulated platelet thromboxane formation from unprocessed tea. Prostaglandins Lcu-kotMed 1987;27:9-13.
24. Lou FQ, Zhang MF, Zhang XG, Liu JM, Yuan WL: A study on tea pigment in prevention of atherosclerosis. Clin Med J 1989;102:579-583.
25. Bingham SA, Magee L, Mulligan A, Runswick S, Cummings JH: Effect of tea drinking on blood lipids, blood pressure and aspects of bowel habit. Br J Nutr, in press.
26. Bingham SA, Gill C, Welch A, Day K, Cassidy A, Khaw KT, Sneyd MJ. Key TJA, Roc L, Day NE: Comparison of dietary assessment methods in nutritional epidemiology. Br J Nutr, in press.
27. Clauss A: Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 1957;237-246.
28. Mehrabian M, Peter JB, Barnard RJ. Lusis AJ: Dietary regulation of fibrinolytic factors. Atherosclerosis 1990;84:25-32.
29. Jerling JC, Vorster HH, Oosthuizen W, Silvis N, Venter CS: Differences in plasminogen activator inhibitor 1 activity between blacks and whites may be diet related. Haemostasis 1994;24:364-368.
30. Vorster HH, Venter CS: Fibrinogen-A cardiovascular risk factor. Car-diovasc J S Afr 1994,5:117-124.
31. Sato Y, Nakatsuka H, Watanabc T, Hisamichi S, Shimiza H, Fujisaku S, Ichinowatari Y, Ida Y, Suda S, Kato K, Ikeda M: Possible contribution of green tea drinking habits to the prevention of stroke. Tohoku J Exp Med 1989;157:337-343.
32. Bak AA, Grobbee DE: Coffee, caffeine and hemostasis: A review. Neth J Med 1990;37:242-246.
33. Veenstra J. Kluft C, Ockhuizcn T, Pikaar NA, vd Pol H, Wedel M, Schaufsma G: Effects of four days of moderate wine and coffee consumption on fibrinolysis and platelet aggregation. Fibrinolysis 1990;4:215-220.